Clinical Significance of Estrogen Receptor β in Breast and Prostate Cancer from Biological Aspects

Overview

Journal Cancer Sci

Specialty Oncology

Date 2015 Jan 23

PMID 25611678

Citations 53

Authors

Yoko Omoto

Hirotaka Iwase

Affiliations

Soon will be listed here.

Abstract

Breast and prostate cancers are among the most common of all cancers. They are referred to as hormone-dependent cancers, because estrogen and androgen are involved in their development and growth. The effects of these hormones are mediated by their respective receptors, estrogen receptor (ER) α and androgen receptor. Around 18 years ago, a second ER, ERβ, which has a very similar structure to ERα, was discovered. Its function has been investigated using a variety of methods and biological systems, leading to our present understanding that ERβ can interact with or inhibit ERα and androgen receptor function directly and/or indirectly, suppress cell growth, and influence responsiveness to endocrine therapy. In order to apply the "inhibition of cell growth" function to cancer treatment, several specific ERβ agonists have been synthesized and are being tested for effectiveness in cancer treatment. We need to keep our eyes on ERβ.

Citing Articles

Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets.

Xu G, Yu J, Lyu J, Zhan M, Xu J, Huang M Adv Sci (Weinh). 2024; 11(46):e2401041.

PMID: 39418072 PMC: 11633542. DOI: 10.1002/advs.202401041.

The Etiology and Pathogenesis of Benign Prostatic Hyperplasia: The Roles of Sex Hormones and Anatomy.

Xu G, Dai G, Huang Z, Guan Q, Du C, Xu X Res Rep Urol. 2024; 16:205-214.

PMID: 39345801 PMC: 11430843. DOI: 10.2147/RRU.S477396.

All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.

El Habre R, Aoun R, Tahtouh R, Hilal G BMC Cancer. 2024; 24(1):615.

PMID: 38773429 PMC: 11106948. DOI: 10.1186/s12885-024-12379-3.

Machine learning-assisted high-content imaging analysis of 3D MCF7 microtissues for estrogenic effect prediction.

Li H, Seada H, Madnick S, Zhao H, Chen Z, Li F Sci Rep. 2024; 14(1):2999.

PMID: 38316851 PMC: 10844358. DOI: 10.1038/s41598-024-53323-6.

Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.

Banjare L Anticancer Agents Med Chem. 2023; 24(4):288-303.

PMID: 37921212 DOI: 10.2174/0118715206265278231026101739.

References

Fritz W, Wang J, Eltoum I, Lamartiniere C . Dietary genistein down-regulates androgen and estrogen receptor expression in the rat prostate. Mol Cell Endocrinol. 2002; 186(1):89-99. DOI: 10.1016/s0303-7207(01)00663-3. View

Webb P, Nguyen P, Valentine C, Lopez G, Kwok G, McInerney E . The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol Endocrinol. 1999; 13(10):1672-85. DOI: 10.1210/mend.13.10.0357. View

Baselga J, Campone M, Piccart M, Burris 3rd H, Rugo H, Sahmoud T . Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med. 2011; 366(6):520-9. PMC: 5705195. DOI: 10.1056/NEJMoa1109653. View

Chu S, Fuller P . Identification of a splice variant of the rat estrogen receptor beta gene. Mol Cell Endocrinol. 1997; 132(1-2):195-9. DOI: 10.1016/s0303-7207(97)00133-0. View

Lin C, Strom A, Kong S, Kietz S, Thomsen J, Tee J . Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res. 2007; 9(2):R25. PMC: 1868918. DOI: 10.1186/bcr1667. View

Bonkhoff H, Berges R . The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol. 2008; 55(3):533-42. DOI: 10.1016/j.eururo.2008.10.035. View

Dey P, Strom A, Gustafsson J . Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. Oncogene. 2013; 33(33):4213-25. DOI: 10.1038/onc.2013.384. View

Horvath L, Henshall S, Lee C, Head D, Quinn D, Makela S . Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res. 2001; 61(14):5331-5. View

Shaaban A, Green A, Karthik S, Alizadeh Y, Hughes T, Harkins L . Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res. 2008; 14(16):5228-35. DOI: 10.1158/1078-0432.CCR-07-4528. View

10.

Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T . Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer. Biochem Biophys Res Commun. 2001; 289(3):692-9. DOI: 10.1006/bbrc.2001.6038. View

11.

Prins G, Birch L . Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology. 1997; 138(5):1801-9. DOI: 10.1210/endo.138.5.5106. View

12.

Honma N, Horii R, Iwase T, Saji S, Younes M, Takubo K . Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol. 2008; 26(22):3727-34. DOI: 10.1200/JCO.2007.14.2968. View

13.

Porter W, Saville B, Hoivik D, Safe S . Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol. 1997; 11(11):1569-80. DOI: 10.1210/mend.11.11.9916. View

14.

Roger P, Sahla M, Makela S, Gustafsson J, Baldet P, ROCHEFORT H . Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001; 61(6):2537-41. View

15.

Lamartiniere C, Cotroneo M, Fritz W, Wang J, Mentor-Marcel R, Elgavish A . Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr. 2002; 132(3):552S-558S. DOI: 10.1093/jn/132.3.552S. View

16.

Walter P, Green S, Greene G, Krust A, Bornert J, Jeltsch J . Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A. 1985; 82(23):7889-93. PMC: 390875. DOI: 10.1073/pnas.82.23.7889. View

17.

Paech K, Webb P, Kuiper G, Nilsson S, Gustafsson J, Kushner P . Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997; 277(5331):1508-10. DOI: 10.1126/science.277.5331.1508. View

18.

Oliveira A, Coelho P, Guedes F, Mahecha G, Hess R, Oliveira C . 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats. Steroids. 2007; 72(14):914-22. DOI: 10.1016/j.steroids.2007.08.001. View

19.

Omoto Y . Estrogen receptor-alpha signaling in growth of the ventral prostate: comparison of neonatal growth and postcastration regrowth. Endocrinology. 2008; 149(9):4421-7. DOI: 10.1210/en.2007-1413. View

20.

Weihua Z, Makela S, Andersson L, Salmi S, Saji S, Webster J . A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci U S A. 2001; 98(11):6330-5. PMC: 33468. DOI: 10.1073/pnas.111150898. View